---
document_datetime: 2025-01-29 16:36:11
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/celldemic-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: celldemic-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 1.1626726
conversion_datetime: 2025-12-24 15:59:11.064457
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Celldemic

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                                                                                 | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                                                                                                                                                                                                     |
|----------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| WS/2707              | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. C.I.13 - Other variations not specifically covered elsewhere in this Annex which involve the submission | 14/11/2024                          |                                             | SmPC                             | Celldemic SmPC sections 4.2, 4.4, 4.8 and 5.1 have been modified to include information on the heterologous booster response. For more information, please refer to the Summary of Product Characteristics. |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| of studies to the competent authority   |
|-----------------------------------------|